CV Sciences Inc (CVSI)

[Wolf-man jack]

THIS IS ALL YQU NEED TO KNOW ABOUT CV SCIENCES AND THE CBD FUTURE MARKET

BREAKING NEWS FEBRUARY 13,2026

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177295726

CV Sciences, Inc. Achieves Industry’s First Hemp Extract GRAS Self-Affirmation
Download as PDFSeptember 10, 2018

https://ir.cvsciences.com/press-releases/detail/85/cv-sciences-inc-achieves-industrys-first-hemp-extract

CV SCIENCES
https://www.cvsciences.com/

ELEVATED SOFTGELLS - CV SCIENCES WHOLLY OWNED SUBSIDIARY
https://elevatedsoftgels.com/

CULTURED FOODS - CV SCIENCES WHOLLY OWNED SUBSIDIARY
https://culturedfoods.eu

LUNAR FOX FOOD COMPANY - CV SCIENCES WHOLLY OWNED SUBSIDIARY
https://www.lunarfoxfoods.com


BREAKING NEWS FEBRUARY 12, 2026

Corn_kernel
Thursday, February 12, 2026 1:17:16 PM

CBD Regulatory & Macro Outlook panel, hosted by Pablo Zuanic on X with guests: Joseph Dowling, CEO, CV_Sciences: Jared Stanley, Co-founder & Board Member, Charlottesweb: and John Harloe, General Counsel, CBDistillery.

LINK ¥
https://x.com/420Odysseus/status/202168892642818490


Saturday, February 14, 2026 10:26:01 AM

It’s all laid out in the PR, coming soon, expect PR announcing…

“The acquisition creates opportunity for importation of these specialty foods to the U.S. AND ESTABLISHES A EUROPEAN BASE OF OPERATIONS FOR THE SALE AND DISTRIBUTION OF +PlusCBD PRODUCTS, OPENING DOORS TO NUMEROUS NEW RETAIL AND DISTRIBUTOR PARTNERS.”

Enjoy Reading:
https://ir.cvsciences.com/press-releases/detail/219/cv-sciences-inc-acquires-cultured-foods-to-enter

https://culturedfoods.eu/

https://ir.cvsciences.com/press-releases/detail/228/cv-sciences-launches-plushlth-a-new-line-of

https://ir.cvsciences.com/press-releases/detail/224/cv-sciences-inc-acquires-elevated-softgels-a-flexible

Enjoy reading:
https://www.reuters.com/business/healthcare-pharmaceuticals/eu-food-agency-sets-safe-consumption-level-hemp-derived-cbd-2026-02-09/

https://i.etsystatic.com/42055322/r/il/c891da/7296956080/il_1588xN.7296956080_n527.jpg


WQLF SAYS: From the article, they failed to mention that our Pro CBD and MJ President TRUMP was coerced to sign the bill that included the legislation that was sucked into the bill at the last minute. In order to pass the bill to open up the Government, President TRUMP knew he could have it nullified in due time. The WISE WQLF mentioned that it would be nullified Ex post facto. And President Trump did just that. Biggly things are going to come to Fruition in the near future. CVSI stock is going to be in my opinion will increase between 500 to 1000 percent 😉 At its current price per share of 0.05 cents that would bring CVSI stock from $0.30 Cents to $0.55 Cents a share. The itsy bitsy spider Web stock is not a good move at this point. It has already increased 1400 percent from $0.520 cents to $0.7722 cents per share. Most of that movement was due to the announcement of the upcoming Medcare Advantage/CBD Pilot Program. It is obvious that CV Sciences CBD will also be announced as a participant in the Medcare Advantage Pilot Program, in the near future. This is obvious from the recent interview with CEO Joseph Dowling and the representatives from the itsy bitsy spider Web Director and CBDistillary Attorney. The WQLFPACK is fortunate to have accumulated MILLIONS of shares between $0.027 and $0.035 cents per share. In my opinion, once CV Sciences becomes one of the selected FEW CBD companies to PARTICIPATE in the upcoming Pilot Program, CVSI price per share will INCREASE dramatically. IMHO YQU Now Understand YQU Understand HAVE MERCY WQLF ahoooooo

THE POST BELOW BY SIR THOMAS @YAHOooooooooo WILL Reinforce my PREMISE YQU Now Understand YQU Understand HAVE MERCY WQLF ahoooooo ¥¥¥¥¥¥¥¥

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177298518

From the article
¥
"Under spending legislation the president signed, cannabinoid products containing even trace amounts of THC would be prohibited once again, which stakeholders say would effectively upend the already struggling marketplace."

"As of the end of the trading day on February 13, 2026, the 52-week low for Charlotte's Web Holdings, Inc. (CWBHF) stock is approximately $0.0520.
52-Week Range: The stock has traded between $0.0520 and $0.7722 over the past 52 weeks.


Friday, February 13, 2026 4:01:45 AM

WQLF SAYS: Thank YQU for the most rewarding post. Is it plausible that Charlotte's Web, and CV Sciences are the three likely candidates for the Pilot Program? HAVE MERCY WQLF ahoooooo

Dr. Joong J Fang Said: What do Charlotte's Web, CV Sciences, and CBD Distillery have in common? A Great Relationship and GRAS.

CBDistillery (via parent company Balanced Health Botanicals) announced in November 2019 that its hemp-derived CBD isolate and full-spectrum oil received "self-affirmed" Generally Recognized as Safe (GRAS) status. This means independent toxicologists reviewed their products, not the FDA.

Key details regarding this status include:

Self-Affirmed, Not FDA-Approved: While CBDistillery completed this review, the FDA has not officially certified any CBD product as GRAS.

Independent Review: The assessment was conducted by qualified experts to meet safety guidelines.
Significance: This move was designed to demonstrate high safety standards and compliance for their hemp-derived extracts.


Ai Generated

Yes, the Medicare Advantage pilot program for CBD is likely to involve more than one company. While Charlotte's Web has been announced as a premier partner for the program, other industry players are actively positioning themselves to participate in this initiative.

Here are the key details regarding participants and the scope of the program:

Key Participant (Charlotte's Web): The company has announced its partnership with the Center for Medicare and Medicaid Innovation (CMMI) to provide hemp-derived CBD products, specifically for senior oncology patients, beginning in early 2026.

Industry Positioned to Participate: Other companies, such as High Tide (through its brands NuLeaf Naturals and FAB CBD), are developing Medicare-aligned product categories in anticipation of participating in this new Medicare Advantage supplemental benefit. Additionally, CV Sciences, Inc. has stated it is "strongly positioned to participate" in the pilot program.

Regulatory Requirements: The program will require strict compliance and quality standards, which suggests that only companies with rigorous, audited, and compliant products (such as those with Good Manufacturing Practices) will likely be involved.

Structure: The initiative is designed to test how CBD fits into Medicare's financial and clinical structure, suggesting a, potentially, multi-vendor approach to evaluate different products.
The program is expected to launch as early as April 2026, offering up to $500 in annual coverage for eligible seniors.

No, cbdMD products are not Generally Recognized as Safe (GRAS) certified by the FDA, as the FDA has not declared any CBD products GRAS. While cbdMD has engaged in internal, self-affirmed GRAS initiatives to strengthen their regulatory position, the FDA maintains that CBD is not recognized as safe for food, dietary supplements, or animal feed.
Key Details Regarding cbdMD Regulations:

No FDA GRAS Certification: The FDA has explicitly stated it cannot conclude that CBD is GRAS due to limited safety data.
Internal Initiatives:

cbdMD is working on its own "self-affirmed" GRAS and regulatory science program to prepare for potential future regulations, rather than having an FDA-granted certification.
GMP Registration: While not GRAS, cbdMD has earned NSF International's Good Manufacturing Practice (GMP) registration, indicating high manufacturing standards.

Labeling Limitations: The FDA prohibits marketing CBD by adding it to food or labeling it as a dietary supplement.
As of early 2026, cbdMD is actively building a regulatory foundation to align with expected future federal oversight, but their current products do not hold a formal FDA GRAS designation.



BULLISH